Purpose: To examine the relationship of increased ocular asymmetry over time to vision-related quality of life in keratoconus. Methods: The subjects were from the Collaborative Longitudinal Evaluation of Keratoconus Study and had complete data on a least 1 scale of the National Eye Institute Visual Function Questionnaire and examination data at baseline and at least 1 follow-up visit. Three measures of disease asymmetry [visual acuity (VA), corneal curvature, and refractive error] and better eye status were assessed. Multilevel models were fit to the data.
K eratoconus is a progressive binocularly asymmetric thinning of the cornea. 1, 2 Corneal thinning leads to irregular astigmatism and distorted vision, which negatively affect keratoconus patients' vision-related quality of life, as measured by the National Eye Institute Visual Function Questionnaire (NEI-VFQ). 3, 4 Despite relatively good visual acuity (VA), 5, 6 keratoconus patients report vision-related qualityof-life scores similar to patients with moderate to severe age-related macular degeneration. 3 With time, most aspects of keratoconus patients' vision-related quality-of-life decline. The factors most closely associated with poor vision-related quality of life are poor VA and steep corneal curvature. 3 Over time, decreases in VA and corneal steepening are associated with decreases in vision-related quality of life. 4 Asymmetry increases with disease severity in keratoconus patients 7 and so the vision-related quality of life may decline as asymmetry increases; however, it is assumed that binocular VA is equal to or better than the vision of the eye that sees most clearly 8 and so vision-related quality of life would not necessarily decline with increasing asymmetry. No previous publications have examined the association between disease asymmetry and vision-related quality of life in keratoconus patients. This article explores the effect of increased ocular asymmetry as measured by VA, corneal curvature, and refractive error (controlling for disease severity) on vision-related quality of life.
METHODS
The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study is a multicenter observational study of the natural progression of keratoconus. Details of the methods of the CLEK Study have been previously presented, 5 and a brief description of the same is given in the present study. Between May 1995 and June 1996, 1209 subjects were enrolled. The protocol was approved by the institutional review board of each clinic, and all subjects provided informed consent. The inclusion criteria were that the potential subject was aged at least 12 years; had an irregular cornea in either eye as determined by the distortion of keratometric mires or of the red or retinoscopic reflex; and had at least one biomicroscopic sign, including Vogt striae, Fleischer ring of 2 mm or more of arc, or corneal scarring typical of keratoconus. Potential subjects did not qualify if they had bilateral corneal transplants or nonkeratoconic eye disease in either eye.
Three indicators of disease status were considered in this study: VA, corneal curvature, and refractive error. Binocular high-contrast logarithm of the minimum angle of resolution (logMAR) VA was assessed according to a standardized protocol 5, 9 while patients wore their habitual vision correction. Corneal curvature was specified by computing the average of 2 keratometric measurements of the steep corneal meridian of each eye. Refractive error was measured by manifest refraction using standard subjective techniques with additional methods, such as large steps between choices, high-powered Jackson crossed cylinder lenses, and subjective cylinder axis orientation. Spherical equivalent refractive error was calculated from the manifest sphere and cylinder.
All CLEK subjects completed the 25-item NEI-VFQ annually beginning with the second examination; the NEI-VFQ was not readily available before the second visit. [10] [11] [12] All subjects in the study presented here were required to have completed the NEI-VFQ at the second examination. All eligible data on or after this visit were used, beginning with the second examination. In what follows, "baseline" refers to the second visit. Data from a visit were included if there were NEI-VFQ responses and if indicators of disease status were available for both eyes. If an eye had a corneal transplant, all data collected after the transplantation were treated as missing.
Twelve scales are contained in the NEI-VFQ. The scale scores were computed according to the algorithm developed by Mangione et al, 10 and they ranged from 0 (worst) to 100 (best). The distribution of the responses presented an issue for some of the quality-of-life scales. Two scales, the dependency scale and the social functioning scale, showed signs of a ceiling effect where at least 70% of the responses were 100. Four other scales had limited variability (ie, no more than 5 different responses): health perception, general vision, color vision, and peripheral vision. The analyses, therefore, used only the following scales: distance activities, driving, mental health, near activities, ocular pain, and role difficulties.
The outcome of interest was the change in the quality of life. The goal was to assess whether deterioration in the disease status of a subject's better eye or increase in the difference in the status of both the eyes in a subject correlated with a change in quality of life. For each disease indicator, the better eye was determined by comparing the within-eye averages of the indicator over the subject's visits. The indications for the better eye are as follows: VA, the eye with the lower average logMAR VA; spherical equivalent refractive error, the eye with the spherical equivalent closest to the plano; and keratometry in the steep meridian, the eye with the flatter average keratometry value. Asymmetry was defined as the difference between the 2 eyes for each of these variables. Binocular VA was also included in models as a predictor to determine whether there was a different effect than the one seen for the VA in the better eye.
For each quality-of-life scale and each indicator of disease status, a multilevel model was fit to assess the relationship between the change in quality of life and the change in disease status. The model assumed that the change in a quality-of-life scale was continuous and normally distributed. It controlled for the passage of time, gender, baseline age, disease status, and scale score. For each scale, a visual inspection of the scale score change over time indicated that a linear model in time was an acceptable fit. Information from all visits was incorporated into the model to account for the variation in quality of life over the course of the study rather than just assessing change as a simple difference between the last and first study visit.
The model included one interaction between baseline scale score and time to account for those with higher baseline scores who have less room to improve on a given scale score due to ceiling effects (100 points). The model also adjusted for the baseline value of the disease indicator in the better eye and the baseline value of disease asymmetry. The predictors of most interest to this research were the change in the disease severity in the better eye and the change in asymmetry, both relative to baseline.
For the purpose of modeling, VA was converted to logMAR and multiplied by a factor of 10. This results in VA effect estimates that represent a change in logMAR of 0.1 units (1 line). In addition to considering change in quality of life as a continuous variable, we dichotomized the change. A decrease in quality of life relative to baseline of 10 or more units was viewed as indicating a meaningful change in the quality of life. Generalized estimating equations were used to assess the relationship between at least a 10-point decrease in a quality-of-life scale and measures of asymmetry while accounting for the repeated measures.
RESULTS
A total of 961 subjects who had complete data for at least 1 scale, 1 disease status indicator at baseline, and at least 1 subsequent visit were included in the study. The number of subjects and visits used to fit a model depended on the scale and the disease status indicator. The most data were available for VA models, where 4 of the 6 scales used 5692 observations from the 961 subjects. The least data were available for the corneal curvature models, where 4 of the 6 scale analyses used 5636 observations from 953 subjects. One scale analysis, driving, used only 5337 observations from 911 subjects.
Demographic data and the pertinent clinical features considered in the article are presented in Table 1 . The average age of the subjects included in these analyses was 40.2 ± 10.8 years (range, 13-78 years). Forty-five percent of the subjects were women and 71% were white. The number of visits ranged from 2 to 8, with a mean follow-up time of 6.3 ± 1.7 years.
Eighty-five percent of the subjects wore at least 1 contact lens (CL). There was no asymmetry in CL wear (ie, same wearing time between eyes) for almost 94% of the visits, and for a little less than half of the visits, the reported change in the wearing time between visits was zero. Because of the negligible asymmetry, CL wear was not considered further in the analyses.
Also shown in Table 1 are the baseline values, by worse and better eye, for the 3 different visual status variables. The average baseline logMAR VA in the better eye was 0.08 (about 20/24), whereas the average logMAR VA in the other eye was 0.29 (20/39). The average logMAR VA asymmetry at baseline was about 0.24 (±0.28). The average spherical equivalent refractive error in the better eye was −5.28 diopters (D) compared with an average of about −8.00 D in the weaker eye. This represents an average asymmetry of about 2.75 D. The average asymmetry at baseline in the keratometric reading of the steep meridian was about 4.60 D, with the better eye value being 48.40 D on average. Because identification of the better eye was determined across all visits within a subject, the baseline asymmetry was not simply the difference between the better and the worse eyes at baseline. Table 2 displays the average observed change from baseline for each scale. Four of the scales have, on average, exhibited a small increase in the score relative to baseline (distance activity, driving, mental health, ocular pain), whereas the other 2 scales decreased slightly (near activity, role difficulty). Table 3 displays, by disease indicators, the average observed change in asymmetry and status of the better eye relative to the baseline values. On average, all measures of disease status became more extreme. Asymmetry increased over all the indicators, VA became worse in the better eye, corneal curvature steepened, and the refractive error became more myopic. Table 4 presents the results of interest to this study, namely the effects of change in performance of the better eye and change in disease asymmetry on the quality of life. Model parameter estimates are adjusted for the following variables: gender, baseline age, baseline quality-of-life scale score, an interaction between baseline score and time, the baseline status in the better eye, and baseline asymmetry. Across all the scales except ocular pain, there was considerable evidence that there was a decrease in quality of life as asymmetry increased and the better eye worsened in VA and its cornea steepened. So, for example, for the distance activity scale, an increase in asymmetry of 0.1 units logMAR acuity resulted in a decrease of 0.33 units on this scale. A decrease in 0.1 units logMAR acuity in the better eye resulted in a drop of 0.99 units on the distance activity scale. To demonstrate the A positive change in asymmetry indicates increasing asymmetry, a positive change in the better eye indicates the eye declined for logMAR and corneal curvature, and a negative change in spherical equivalent indicates increased myopia. effect graphically, the distance activity scale is chosen as an example. Figure 1 presents the predicted change in quality of life based on the change in the better eye, and Figure 2 shows the predicted change in quality of life based on the change in asymmetry for the distance activity scale.
For the steep meridian on keratometry, a 1.00-D increase in asymmetry between the eyes resulted in a decrease in the distance activity scale of 0.23 units, whereas a 1.00-D increase in the better eye resulted in a decrease of 0.43 units. There was little evidence that a refractive error change in asymmetry or in the better eye changed the quality of life. On those scales with statistically significant effects for both change in the asymmetry and change in the better eye, the change in the better eye represented the larger of the 2 effects. This indicates that the better eye had more influence on the quality-of-life outcome than asymmetry. Table 5 presents the associated odds ratios (ORs) for the effect of change in the asymmetry and the change in the better eye on the chance of a 10-point decrease in the NEI-VFQ scales. As in quality of life for the continuous measure, refractive error was not associated with a decrease in any scale of quality of life, either for change in the asymmetry or for change in the better eye. For the remaining indicators of visual status, a change in the better eye was associated with a statistically significant increase in the OR of a 10-unit decrease in quality of life with a few exceptions (ocular pain and VA measures, driving and corneal curvature). The magnitudes of the ORs were small, between 1.07 and 1.36. Increasing asymmetry was statistically significantly associated with a 10-point decrease in the driving and near activity quality-of-life scales for both VA measures and corneal curvature, as well as for monocular VA and corneal curvature for the distance activity quality-of-life scale. The magnitude of the effect was quite small though, on the order of ORs from 1.03 to 1.06.
DISCUSSION
Although the changes in quality of life in CLEK's keratoconus subjects have been explored previously, 4 we were interested in looking at the possible relationship between the change in asymmetry and quality of life. Of particular interest was a comparison of the effect of the better eye compared with the effect of the asymmetry. Consistent with the original article, average quality-of-life changes were small, 4 and the various asymmetry parameters described were consistent with other publications. 7, 13, 14 The changes in the quality-of-life scales were associated with the changes in the asymmetry of VA and corneal curvature as well as the changes in the better eye, with few exceptions. The differences for refractive error, either measured by change in the better eye or change in the asymmetry, were not statistically significant, for the most part, possibly because changes in refractive error are generally correctable by simple changes in refractive correction; however, none of the changes in the quality-of-life scales would be considered clinically relevant; the largest change approaches 1 unit on the quality-of-life scale that ranges from 0 to 100. Overall, if one were to pick the variable, asymmetry or better eye, that had a larger effect size, and therefore more influence, it would be the change in the better eye.
Comparing the results of the changes in quality of life for the VA in the better-seeing eye with the binocular VA indicated that there was very little difference between the 2 measures of acuity. This was true whether the outcome was the continuous measure of quality of life or a large decrease in quality of life as measured by a 10-unit decrease.
Relatively few studies have presented longitudinal data related to the NEI-VFQ and disease state. Matza et al 15 examined data in a study of VA in subjects with diabetic retinopathy. Over 18 months, changes on the same scales as we present ranged from small (0.1 units) to large (−22.9 units), depending on the scale and the change in VA. For example, a decrease in VA of 10 letters or more corresponded to an average decrease in the driving scale of 22.9 units. Those with little change in VA experienced quality-of-life changes between −1.8 and 2.2 units. 15 The Age-Related Eye Disease Study Research Group looked at a 15-letter decrease in VA over a 1-to 4-year time frame from questionnaire administration. There was relatively no change in ocular pain (+0.08 units), whereas the largest difference seen was for the driving scale, a decrease of 22.2 units. 16 Subjects in the Los Angeles Latino Eye Study reported differences between −0.3 units (driving) and +3.5 units (mental health), on average, from baseline to the 4-year follow-up visit. 17 For those experiencing no VA change (within 2 lines of 20/20), the mean change in the quality of life ranged from −0.05 units (distance activities) to +3.1 units (ocular pain), whereas among those subjects who experienced at least 2 lines, the mean change was between 0.6 units (near activities) and −12.7 units (driving).
Visual changes in diabetic retinopathy and macular degeneration cannot be corrected by changes in refractive correction, whereas most changes in VA, corneal curvature, and refractive error (as measured in this investigation and the Los Angeles Latino Eye Study) can be corrected with some form of visual correction. This is why the changes in the 4 evaluated the same large change in the quality of life (10 points) in the CLEK Study for a large decrease in binocular acuity (10 letters) and a large increase (3.00 D) in corneal curvature. The ORs associated with a 10-point decline in these quality-of-life scales were of a much larger magnitude (ORs = 1.62-3.49 for corneal curvature and 1.20-2.19 for binocular VA) than for a 1-D change in corneal curvature asymmetry or a 0.1-unit (5 letters/line) change in VA asymmetry. This indicates that, using the same sample, the impact of asymmetry changing over time is minor compared with other characteristics of the disease process.
Limitations
Visual changes over time due to keratoconus are relatively slow, 18 primarily because of the ability of gas-permeable CL to correct the irregular astigmatism of many keratoconus patients but perhaps also because the subjects are slightly older at baseline (on average 40.2 years), so that they may be progressing less. Because the VA does not change significantly over time for most keratoconus patients, the quality of life changes very little. The changes in the quality of life in this study were generally not clinically relevant, thereby limiting the results to small changes. Perhaps larger changes in the asymmetry versus larger changes in the better eye would have different effects on the quality of life, but it is difficult to determine from the relatively stable vision of this sample.
CONCLUSIONS
Most clinicians assume that the eye with the best VA drives a patient's quality of life; however, before this investigation, there has never been a comparison of the effects of the best eye compared with differences between the eyes. Because keratoconus leads to relatively large asymmetries between the eyes, the question is particularly important in this disease. According to our findings, vision of the better eye and asymmetry are both important, but the vision of the better eye typically has a stronger effect on vision-related quality of life than the difference between the eyes.
